Context Therapeutics (CNTX) Non-Current Assets (2020 - 2026)

Context Therapeutics has disclosed Non-Current Assets across 7 years of filings, most recently posting $342277.0 for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $342277.0, up 45.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $858552.0 (up 16.83% YoY), and the FY2025 annual result was $140066.0, down 39.31% from the prior year.
• Non-Current Assets came in at $342277.0 for Q1 2026 at Context Therapeutics, up from $140066.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $342277.0 in Q1 2026 to a low of $10388.0 in Q2 2024.
• The 5-year median for Non-Current Assets is $143827.0 (2022), against an average of $141274.3.
• Across the five-year window, Non-Current Assets sank 92.11% in 2022 and surged 1862.51% in 2025, its largest moves.
• Context Therapeutics' Non-Current Assets stood at $112285.0 in 2022, then plunged by 86.17% to $15524.0 in 2023, then soared by 1386.57% to $230775.0 in 2024, then slumped by 39.31% to $140066.0 in 2025, then jumped by 144.37% to $342277.0 in 2026.
• The last three Non-Current Assets figures came in at $342277.0 (Q1 2026), $140066.0 (Q4 2025), and $172343.0 (Q3 2025), per Business Quant data.